scanX
Home
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

1,399.20
-1.20
(-0.09%)
Market Cap
39,483.77
Eps
-53.22
PE Ratio (TTM)
-
Dividend Yield
0.18
Industry
Healthcare
52 Week High
1,830.95
52 Week low
771.00
PB Ratio
4.68
Debt to Equity
0.34
Sector
Pharmaceuticals
Add Ratio
Live Chart

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
6.58 %
Net Income Growth
1,943.30 %
Cash Flow Change
-142.44 %
ROE
2,463.74 %
ROCE
56.66 %
EBITDA Margin (Avg.)
-0.74 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
6,652
7,582
9,117
9,166
10,074
10,801
10,994
12,472
11,872
12,653
13,133
Expenses
5,607
6,125
7,043
7,459
8,280
8,943
8,860
9,985
9,948
10,618
11,285
EBITDA
1,044
1,457
2,074
1,707
1,794
1,858
2,135
2,487
1,924
2,035
1,847
Operating Profit %
15 %
19 %
22 %
18 %
16 %
16 %
19 %
19 %
14 %
10 %
5 %
Depreciation
260
234
264
302
326
417
444
487
569
582
537
Interest
190
179
237
286
335
377
353
298
349
516
371
Profit Before Tax
594
1,044
1,491
1,119
1,301
1,096
1,383
1,441
240
37
1,088
Tax
119
301
383
316
376
320
412
448
329
1,867
1,938
Net Profit
475
743
1,109
804
925
776
970
994
-90
-1,831
-850
EPS in ₹
17.52
26.47
39.29
28.49
32.78
27.50
34.38
33.37
10.53
-53.22
-31.00
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
9,688
10,193
11,764
12,595
13,296
14,685
15,604
17,083
19,372
14,359
Fixed Assets
2,836
2,594
2,755
3,030
3,670
5,029
5,129
5,887
5,422
4,210
Current Assets
5,323
5,904
6,875
6,989
6,697
6,804
7,360
8,282
10,726
7,428
Capital Work in Progress
492
543
708
1,122
1,399
1,222
1,382
1,010
1,190
662
Investments
0
17
16
15
30
25
25
50
45
790
Other Assets
6,359
7,039
8,285
8,429
8,197
8,410
9,068
10,137
12,716
8,697
Total Liabilities
9,688
10,193
11,764
12,595
13,296
14,685
15,604
17,083
19,372
14,359
Current Liabilities
3,711
3,999
2,703
3,288
4,021
4,126
4,201
4,689
5,105
5,819
Non Current Liabilities
2,976
2,564
4,569
4,144
3,670
4,489
4,338
2,956
4,427
693
Total Equity
3,000
3,629
4,492
5,163
5,605
6,070
7,064
9,438
9,839
7,848
Reserve & Surplus
2,973
3,601
4,464
5,135
5,577
6,042
7,036
9,058
9,446
7,820
Share Capital
27
28
28
28
28
28
28
28
28
28
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-31
93
199
177
-297
174
28
272
33
215
Investing Activities
-712
-950
-1,001
-1,003
-883
-774
-662
-316
-515
4,387
Operating Activities
482
345
657
1,648
1,324
1,392
1,131
1,109
625
-265
Financing Activities
199
699
543
-469
-739
-445
-442
-521
-78
-3,906
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
46.63 %
46.63 %
46.65 %
46.65 %
46.65 %
46.65 %
46.65 %
46.65 %
46.65 %
46.65 %
46.65 %
46.65 %
46.64 %
46.65 %
46.65 %
46.65 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
24.80 %
23.71 %
21.38 %
20.98 %
23.05 %
23.51 %
DIIs
3.82 %
4.94 %
5.09 %
7.08 %
6.62 %
6.01 %
10.64 %
10.69 %
10.41 %
9.11 %
10.32 %
10.92 %
13.36 %
13.92 %
13.21 %
13.85 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.04 %
0.04 %
0.04 %
0.04 %
0.04 %
0.04 %
0.04 %
0.04 %
0.04 %
0.04 %
Public / Retail
15.92 %
14.43 %
16.02 %
15.88 %
15.88 %
16.32 %
16.47 %
16.72 %
16.90 %
15.20 %
14.83 %
14.77 %
14.83 %
14.58 %
13.61 %
12.65 %
No of Share Holders
2,50,849
2,75,801
3,29,870
3,17,383
3,10,516
3,12,473
3,13,540
3,00,106
2,85,461
2,36,908
2,32,685
2,09,931
1,99,451
1,92,630
1,93,949
1,95,059

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 2 2 2 2.5 2.5 2.5 2.5 2.5 0.00
Dividend Yield (%) 0.00 0.38 0.31 0.97 0.54 0.57 0.56 0.26 0.18 0.00

Announcements

Announcement under Regulation 30 (LODR)-Press Release / Media Release
7 days ago
Intimation Of Change In The Name Of The Step Down Wholly Owned Subsidiaries Of The Company.
Jan 08, 2025, 17:12

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,705.50 4,09,206.58 38.22 49,887.20 12.06 9,648 27.34 34.79
Divis Laboratories
5,410.20 1,43,623.81 80.60 8,184.00 0.89 1,600 46.55 30.72
Cipla
1,420.60 1,12,751.00 24.42 26,520.70 14.17 4,155 47.38 39.95
Torrent Pharmaceuticals
3,314.80 1,12,187.89 60.63 10,785.70 11.59 1,656 13.54 53.49
Mankind Pharma
2,456.70 1,01,355.31 49.70 10,615.60 19.57 1,942 -16.38 38.34
Dr Reddys Laboratories
1,181.25 98,564.79 18.60 28,905.40 12.36 5,578 1.69 23.79
Lupin
2,022.35 92,259.11 36.10 20,141.50 19.94 1,936 73.53 32.95
Zydus Life Science
910.25 91,592.45 21.70 19,831.50 13.82 3,831 14.57 33.91
Aurobindo Pharma
1,138.60 66,130.07 18.88 29,559.20 17.55 3,169 8.66 36.75
Alkem Laboratories
4,916.05 58,778.75 27.24 12,978.40 9.84 1,812 14.16 25.91

Corporate Action

Technical Indicators

RSI(14)
Neutral
30.12
ATR(14)
Volatile
48.23
STOCH(9,6)
Neutral
29.13
STOCH RSI(14)
Oversold
2.15
MACD(12,26)
Bearish
-13.50
ADX(14)
Strong Trend
26.03
UO(9)
Bearish
43.45
ROC(12)
Downtrend But Slowing Down
-9.24
WillR(14)
Oversold
-88.38
Bearish
3
Neutral
4
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Fundamental Screeners
Intraday Screeners
Technical Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.